Evaluation of caspase-3 overexpression as a chemosensitizer in tumor gene therapy
碩士 === 國立臺灣大學 === 獸醫學研究所 === 90 === Abstract Abnormality in apoptosis is deeply involved in oncogenesis and the malignant progression of cancers. To trigger the tumor cells undergo apoptosis is the aim of most tumor treatment. Today, the most chemotherapeutic agents kill tumor cells by...
Main Author: | 張鈺偵 |
---|---|
Other Authors: | 鄭謙仁 |
Format: | Others |
Language: | en_US |
Published: |
2001
|
Online Access: | http://ndltd.ncl.edu.tw/handle/24152643749845235263 |
Similar Items
-
Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts
by: Strunk Timo, et al.
Published: (2005-06-01) -
Targeting SREBP1 chemosensitizes colorectal cancer cells to gemcitabine by caspase-7 upregulation
by: Wenlong Shen, et al.
Published: (2019-01-01) -
METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation
by: Liu Z, et al.
Published: (2020-12-01) -
Caspase-1 as a target of bacterial tumor therapy
by: Galmbacher, Katharina Monika
Published: (2008) -
RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways
by: Tianze Liu, et al.
Published: (2018-04-01)